Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease

por Busaidy, Naifa Lamki, Cabanillas, Maria E.
Publicado 2012

The treatment landscape in thyroid cancer: a focus on cabozantinib

por Weitzman, Steven P, Cabanillas, Maria E
Publicado 2015

Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond

por Rao, Sarika N, Cabanillas, Maria E
Publicado 2018

Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer

por Fullmer, Tanner, Cabanillas, Maria E., Zafereo, Mark
Publicado 2021

Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer

por Cabanillas, Maria E., Hu, Mimi I., Durand, Jean-Bernard, Busaidy, Naifa L.
Publicado 2011

Thyroid Oncology

por M. Bugalho, Maria João, Wohllk, Nelson, Hoff, Ana O., Cabanillas, Maria E.
Publicado 2011

PSAT225 Severe Hypercalcemia Following Denosumab Withdrawal in Giant Cell Tumor of Bone: A Double-edged Sword Treatment Paradigm?

por Deepika, F N U, Patil, Madhuri D, Cabanillas, Maria E, Guise, Theresa A
Publicado 2022

Bilateral spontaneous pneumothoraces in anaplastic thyroid cancer

por Kazzaz, Farah I., Cabanillas, Maria E., Bashoura, Lara, Shannon, Vickie R., Faiz, Saadia A.
Publicado 2019

Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance

por Hamidi, Sarah, Hofmann, Marie-Claude, Iyer, Priyanka C., Cabanillas, Maria E., Hu, Mimi I., Busaidy, Naifa L., Dadu, Ramona
Publicado 2023

Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model

por Danysh, Brian P., Rieger, Erin Y., Sinha, Deepankar K., Evers, Caitlin V., Cote, Gilbert J., Cabanillas, Maria E., Hofmann, Marie-Claude
Publicado 2016

Decision Making When Cancer Becomes Chronic: Needs Assessment for a Web-Based Medullary Thyroid Carcinoma Patient Decision Aid

por Shojaie, Danielle, Hoffman, Aubri S, Amaku, Ruth, Cabanillas, Maria E, Sosa, Julie Ann, Waguespack, Steven G, Zafereo, Mark E, Hu, Mimi I, Grubbs, Elizabeth E
Publicado 2021

The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells()

por Puli, Oorvashi Roy, Danysh, Brian P, McBeath, Elena, Sinha, Deepankar K, Hoang, Nguyet M, Powell, Reid T, Danysh, Heather E, Cabanillas, Maria E, Cote, Gilbert J, Hofmann, Marie-Claude
Publicado 2018

Recent advances and emerging therapies in anaplastic thyroid carcinoma

por Cabanillas, Maria E., Zafereo, Mark, Williams, Michelle D., Ferrarotto, Renata, Dadu, Ramona, Gross, Neil, Gunn, G. Brandon, Skinner, Heath, Cote, Gilbert, Grosu, Horiana B., Iyer, Priyanka, Busaidy, Naifa L.
Publicado 2018

PSAT385 Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer

por Vodopivec, Danica M, Cabanillas, Maria E, Busaidy, Naifa L, Gule-Monroe, Maria K, Zafereo, Mark E, Wang, Jennifer R, Williams, Michelle D, Waguespack, Steven G, Bassett, Roland, Maniakas, Anastasios, Lai, Stephen Y, Dadu, Ramona
Publicado 2022

Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples

por Angell, Trevor E., Wirth, Lori J., Cabanillas, Maria E., Shindo, Maisie L., Cibas, Edmund S., Babiarz, Joshua E., Hao, Yangyang, Kim, Su Yeon, Walsh, P. Sean, Huang, Jing, Kloos, Richard T., Kennedy, Giulia C., Waguespack, Steven G.
Publicado 2019

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

por Iyer, Priyanka C., Dadu, Ramona, Gule-Monroe, Maria, Busaidy, Naifa L., Ferrarotto, Renata, Habra, Mouhammed Amir, Zafereo, Mark, Williams, Michelle D., Gunn, G. Brandon, Grosu, Horiana, Skinner, Heath D., Sturgis, Erich M., Gross, Neil, Cabanillas, Maria E.
Publicado 2018

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns

por Nguyen, Ha, Shah, Komal, Waguespack, Steven G, Hu, Mimi I, Habra, Mouhammed Amir, Cabanillas, Maria E, Busaidy, Naifa L, Bassett, Roland, Zhou, Shouhao, Iyer, Priyanka C, Simmons, Garrett, Kaya, Diana, Pitteloud, Marie, Subudhi, Sumit K, Diab, Adi, Dadu, Ramona
Publicado 2021

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer

por Wirth, Lori J., Brose, Marcia S., Sherman, Eric J., Licitra, Lisa, Schlumberger, Martin, Sherman, Steven I., Bible, Keith C., Robinson, Bruce, Rodien, Patrice, Godbert, Yann, De La Fouchardiere, Christelle, Newbold, Kate, Nutting, Christopher, Misir, Soamnauth, Xie, Ran, Almonte, Ana, Ye, Weifei, Cabanillas, Maria E.
Publicado 2021

Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma

por Wang, Jennifer Rui, Montierth, Matthew, Xu, Li, Goswami, Maitrayee, Zhao, Xiao, Cote, Gilbert, Wang, Wenyi, Iyer, Priyanka, Dadu, Ramona, Busaidy, Naifa L., Lai, Stephen Y., Gross, Neil D., Ferrarotto, Renata, Lu, Charles, Gunn, Gary Brandon, Williams, Michelle D., Routbort, Mark, Zafereo, Mark E., Cabanillas, Maria E.
Publicado 2022

Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma

por Waguespack, Steven G, Drilon, Alexander, Lin, Jessica J, Brose, Marcia S, McDermott, Ray, Almubarak, Mohammed, Bauman, Jessica, Casanova, Michela, Krishnamurthy, Anuradha, Kummar, Shivaani, Leyvraz, Serge, Oh, Do-Youn, Park, Keunchil, Sohal, Davendra, Sherman, Eric, Norenberg, Ricarda, Silvertown, Josh D, Brega, Nicoletta, Hong, David S, Cabanillas, Maria E
Publicado 2022